Table 1. Baseline demographic and clinical characteristics of all study participants (mild and moderate).
| Group A (n = 30) | Group B (n = 29) | Group C (n = 30) | ap value | |
|---|---|---|---|---|
| Gender, n (%) | 0.915 | |||
| Male | 6 (20%) | 6 (20.69%) | 5 (16.67%) | |
| Female | 24 (80%) | 23 (79.31%) | 25 (83.33%) | |
| Age (year) ± SE (Range) | 56.33 ± 1.48 (37–71) | 55.45 ± 1.38 (40–68) | 58.13 ± 1.13 (45–66) | 0.356 |
| BH (cm) ± SE (Range) | 158.20 ± 1.41 (143–172) | 159.03 ± 1.31 (147–172) | 155.90 ± 1.09 (145–168) | 0.204 |
| BW (kg) ± SE (Range) | 64.56 ± 2.47 (43–100) | 62.62 ± 2.39 (47–95) | 63.53 ± 1.81 (45–88) | 0.830 |
| DM, n (%) | 0.622 | |||
| No | 29 (96.67%) | 26 (89.66%) | 27 (90%) | |
| Yes | 1 (3.33%) | 3 (10.34%) | 3 (10%) | |
| HTN, n (%) | 0.621 | |||
| No | 24 (80%) | 20 (68.97%) | 22 (73.33%) | |
| Yes | 6 (20%) | 9 (31.03%) | 8 (26.67%) | |
| Lesion site, n (%) | 0.865 | |||
| Right | 14 (46.67%) | 15 (51.72%) | 16 (53.33%) | |
| Left | 16 (53.33%) | 14 (48.28%) | 14 (46.67%) | |
| Duration (month) ± SE (Range) | 34.27 ± 5.85 (4–120) | 35.34 ± 7.45 (4–120) | 34.37 ± 5.42 (6–120) | 0.991 |
Group A: 3 sessions of active rESWT; Group B: 1 session of active rESWT; Group C: 3 sessions of sham rESWT.
SE = Standard error, BH = Body height, BW = Body weight, DM = Diabetes mellitus, HTN = Hypertension.
aOne-way ANOVA test or Chi-square test/Fisher’s exact test.